TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Glycorex Transplantation AB (publ)
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 24,134 | 20,507 | 20,011 |
Financial expenses | 165 | 292 | 251 |
Earnings before taxes | -5,693 | -8,901 | -5,966 |
EBITDA | 166 | -2,435 | 79 |
Total assets | 64,202 | 74,021 | 83,525 |
Current assets | 30,365 | 36,762 | 42,945 |
Current liabilities | 10,573 | 9,832 | 8,435 |
Equity capital | 49,692 | 60,318 | 70,559 |
- share capital | 2,467 | 2,685 | 2,588 |
Employees (average) | 22 | 24 | 22 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 77.4% | 81.5% | 84.5% |
Turnover per employee | 1,097 | 854 | 910 |
Profit as a percentage of turnover | -23.6% | -43.4% | -29.8% |
Return on assets (ROA) | -8.6% | -11.6% | -6.8% |
Current ratio | 287.2% | 373.9% | 509.1% |
Return on equity (ROE) | -11.5% | -14.8% | -8.5% |
Change turnover | 5,288 | 874 | -6,748 |
Change turnover % | 28% | 4% | -25% |
Chg. No. of employees | -2 | 2 | 1 |
Chg. No. of employees % | -8% | 9% | 5% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.